References
1. Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM,
Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, et al. 2023
ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation: A Report of the American College of Cardiology/American
Heart Association Joint Committee on Clinical Practice Guidelines.Circulation . 2024;149:e1-e156. doi:
10.1161/cir.00000000000011932. Schreiber D, Rostock T, Fröhlich M,
Sultan A, Servatius H, Hoffmann BA, Lüker J, Berner I, Schäffer B,
Wegscheider K, et al. Five-year follow-up after catheter ablation of
persistent atrial fibrillation using the stepwise approach and
prognostic factors for success. Circ Arrhythm Electrophysiol .
2015;8:308-317. doi: 10.1161/circep.114.0016723. Verma A, Jiang CY,
Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA,
Haverkamp W, Weerasooriya R, et al. Approaches to catheter ablation for
persistent atrial fibrillation. N Engl J Med . 2015;372:1812-1822.
doi: 10.1056/NEJMoa14082884. Murakawa Y, Nogami A, Shoda M, Inoue K,
Naito S, Kumagai K, Miyauchi Y, Yamane T, Morita N, Okumura K.
Nationwide survey of catheter ablation for atrial fibrillation: the
Japanese Catheter Ablation Registry of Atrial Fibrillation
(J-CARAF)–report of 1-year follow-up. Circ J .
2014;78:1091-1096. doi: 10.1253/circj.cj-14-00995. Fujiki A, Tsuneda T,
Sugao M, Mizumaki K, Inoue H. Usefulness and safety of bepridil in
converting persistent atrial fibrillation to sinus rhythm. Am J
Cardiol . 2003;92:472-475. doi: 10.1016/s0002-9149(03)00672-66. Ono K,
Iwasaki YK, Akao M, Ikeda T, Ishii K, Inden Y, Kusano K, Kobayashi Y,
Koretsune Y, Sasano T, et al. JCS/JHRS 2020 Guideline on Pharmacotherapy
of Cardiac Arrhythmias. Circ J . 2022;86:1790-1924. doi:
10.1253/circj.CJ-20-12127. Yamashita T, Ogawa S, Sato T, Aizawa Y,
Atarashi H, Fujiki A, Inoue H, Ito M, Katoh T, Kobayashi Y, et al.
Dose-response effects of bepridil in patients with persistent atrial
fibrillation monitored with transtelephonic electrocardiograms: a
multicenter, randomized, placebo-controlled,double-blind study (J-BAF
Study). Circ J . 2009;73:1020-1027. doi:
10.1253/circj.cj-08-10618. Thomas L, Abhayaratna WP. Left Atrial Reverse
Remodeling: Mechanisms, Evaluation, and Clinical Significance.JACC Cardiovasc Imaging . 2017;10:65-77. doi:
10.1016/j.jcmg.2016.11.0039. Nishida K, Fujiki A, Sakamoto T, Iwamoto J,
Mizumaki K, Hashimoto N, Inoue H. Bepridil reverses atrial electrical
remodeling and L-type calcium channel downregulation in a canine model
of persistent atrial tachycardia. J Cardiovasc Electrophysiol .
2007;18:765-772. doi: 10.1111/j.1540-8167.2007.00833.x10. Sato D, Niwano
S, Imaki R, Masaki Y, Sasaki S, Yuge M, Hirasawa S, Sasaki T, Moriguchi
M, Niwano H, et al. Bepridil inhibits sub-acute phase of atrial
electrical remodeling in canine rapid atrial stimulation model.Circ J . 2006;70:206-213. doi: 10.1253/circj.70.20611. Fredersdorf
S, Ucer E, Jungbauer C, Dornia C, Eglmeier J, Eissnert C, Hamer OW,
Weber S, Arzt M, von Bary C. Lone atrial fibrillation as a positive
predictor of left atrial volume reduction following ablation of atrial
fibrillation. Europace . 2014;16:26-32. doi:
10.1093/europace/eut15212. Kagawa Y, Fujii E, Fujita S, Ito M.
Association between left atrial reverse remodeling and maintenance of
sinus rhythm after catheter ablation of persistent atrial fibrillation.Heart Vessels . 2020;35:239-245. doi:
10.1007/s00380-019-01475-113. Lang RM, Badano LP, Mor-Avi V, Afilalo J,
Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA,
Kuznetsova T, et al. Recommendations for cardiac chamber quantification
by echocardiography in adults: an update from the American Society of
Echocardiography and the European Association of Cardiovascular Imaging.J Am Soc Echocardiogr . 2015;28:1-39.e14. doi:
10.1016/j.echo.2014.10.00314. Mitchell C, Rahko PS, Blauwet LA, Canaday
B, Finstuen JA, Foster MC, Horton K, Ogunyankin KO, Palma RA, Velazquez
EJ. Guidelines for Performing a Comprehensive Transthoracic
Echocardiographic Examination in Adults: Recommendations from the
American Society of Echocardiography. J Am Soc Echocardiogr .
2019;32:1-64. doi: 10.1016/j.echo.2018.06.00415. Calkins H, Hindricks G,
Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J,
Camm J, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus
statement on catheter and surgical ablation of atrial fibrillation.Heart Rhythm . 2017;14:e275-e444. doi:
10.1016/j.hrthm.2017.05.01216. Tops LF, Delgado V, Bertini M, Marsan NA,
Den Uijl DW, Trines SA, Zeppenfeld K, Holman E, Schalij MJ, Bax JJ. Left
atrial strain predicts reverse remodeling after catheter ablation for
atrial fibrillation. J Am Coll Cardiol . 2011;57:324-331. doi:
10.1016/j.jacc.2010.05.06317. Duytschaever M, Demolder A, Phlips T,
Sarkozy A, El Haddad M, Taghji P, Knecht S, Tavernier R, Vandekerckhove
Y, De Potter T. PulmOnary vein isolation With vs. without continued
antiarrhythmic Drug trEatment in subjects with Recurrent Atrial
Fibrillation (POWDER AF): results from a multicentre randomized trial.Eur Heart J . 2018;39:1429-1437. doi: 10.1093/eurheartj/ehx66618.
Kondo T, Miake J, Kato M, Ogura K, Iitsuka K, Yamamoto K. Impact of
postprocedural antiarrhythmic drug therapy with bepridil on maintaining
sinus rhythm after catheter ablation for persistent atrial fibrillation.J Cardiol . 2016;68:229-235. doi: 10.1016/j.jjcc.2015.09.01219.
Kaitani K, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, Morishima
I, Miura F, Watanabe T, Masuda M, et al. Efficacy of Antiarrhythmic
Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation
(EAST-AF) trial. Eur Heart J . 2016;37:610-618. doi:
10.1093/eurheartj/ehv50120. Darkner S, Chen X, Hansen J, Pehrson S,
Johannessen A, Nielsen JB, Svendsen JH. Recurrence of arrhythmia
following short-term oral AMIOdarone after CATheter ablation for atrial
fibrillation: a double-blind, randomized, placebo-controlled study
(AMIO-CAT trial). Eur Heart J . 2014;35:3356-3364. doi:
10.1093/eurheartj/ehu35421. Yamaguchi T. Atrial structural remodeling
and atrial fibrillation substrate: A histopathological perspective.J Cardiol . 2024. doi: 10.1016/j.jjcc.2024.05.00722. Allessie M,
Ausma J, Schotten U. Electrical, contractile and structural remodeling
during atrial fibrillation. Cardiovasc Res . 2002;54:230-246. doi:
10.1016/s0008-6363(02)00258-423. Lu Z, Scherlag BJ, Lin J, Niu G, Fung
KM, Zhao L, Ghias M, Jackman WM, Lazzara R, Jiang H, et al. Atrial
fibrillation begets atrial fibrillation: autonomic mechanism for atrial
electrical remodeling induced by short-term rapid atrial pacing.Circ Arrhythm Electrophysiol . 2008;1:184-192. doi:
10.1161/circep.108.78427224. Soulat-Dufour L, Lang S, Addetia K, Ederhy
S, Adavane-Scheuble S, Chauvet-Droit M, Jean ML, Nhan P, Ben Said R,
Kamami I, et al. Restoring Sinus Rhythm Reverses Cardiac Remodeling and
Reduces Valvular Regurgitation in Patients With Atrial Fibrillation.J Am Coll Cardiol . 2022;79:951-961. doi:
10.1016/j.jacc.2021.12.02925. Machino-Ohtsuka T, Seo Y, Ishizu T, Yanaka
S, Nakajima H, Atsumi A, Yamamoto M, Kawamura R, Koshino Y, Machino T,
et al. Significant improvement of left atrial and left atrial appendage
function after catheter ablation for persistent atrial fibrillation.Circ J . 2013;77:1695-1704. doi: 10.1253/circj.cj-12-151826.
Fujiki A, Tsuneda T, Sakabe M, Nakagawa K, Mizumaki K, Hirai T, Inoue H.
Maintenance of sinus rhythm and recovery of atrial mechanical function
after cardioversion with bepridil or in combination with aprindine in
long-lasting persistent atrial fibrillation. Circ J .
2004;68:834-839. doi: 10.1253/circj.68.834Figure legends
Figure 1.
Kaplan–Meier analysis of freedom from atrial fibrillation recurrence.
(A) Starting point was defined as the date of ablation procedure. (B)
Starting point was defined as the date of bepridil discontinuation.
Figure 2.
Changes in left atrial volume index before and after catheter ablation
in the short-term continuation group and long-term continuation group.
Box plots show the median, interquartile range, and range of the
results. LA, left atrial; CA, catheter ablation
Figure 3.
Kaplan–Meier analysis of freedom from atrial fibrillation recurrence
according to with or without left atrial reverse remodeling. (A)
Starting point was defined as the date of ablation procedure. (B)
Starting point was defined as the date of bepridil discontinuation. LA,
left atrial